Esai and Biogen, Lequembi manufacturer, receive FDA approval for Alzheimer's drug. Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review. Source 8o.
Sponsored Links:
Post Date:Sun May 12 20:10:48 GMT 2024 / Post ID: #
Comment
Lecanemab
More opinions appreciated on lecanemab is a good topic speedily to find out correct so I can decide for myself.
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,